Properties of odor identification testing in screening for early-stage Alzheimer’s disease

Odor identification (OI) is impaired in the early stages of Alzheimer’s disease (AD). However, data regarding the diagnostic properties of OI tests are lacking, preventing their clinical use. We aimed to explore OI and determine the accuracy of OI testing in screening for patients with early AD. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Audronyte, Egle, Pakulaite-Kazliene, Gyte, Sutnikiene, Vaiva, Kaubrys, Gintaras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102162/
https://www.ncbi.nlm.nih.gov/pubmed/37055436
http://dx.doi.org/10.1038/s41598-023-32878-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102162/
https://www.ncbi.nlm.nih.gov/pubmed/37055436
http://dx.doi.org/10.1038/s41598-023-32878-w

Ejemplares similares